Medical Data Vision Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Hiroyuki Iwasaki
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 11.5yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 10yrs |
Recent management updates
Recent updates
Medical Data Vision Co., Ltd.'s (TSE:3902) 26% Share Price Surge Not Quite Adding Up
Dec 15
Estimating The Fair Value Of Medical Data Vision Co., Ltd. (TSE:3902)
Nov 21Medical Data Vision (TSE:3902) Is Paying Out A Larger Dividend Than Last Year
Oct 28Medical Data Vision Co., Ltd.'s (TSE:3902) Share Price Is Still Matching Investor Opinion Despite 25% Slump
Oct 16Medical Data Vision (TSE:3902) Is Increasing Its Dividend To ¥9.00
Sep 22Medical Data Vision's (TSE:3902) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 14Medical Data Vision Co., Ltd.'s (TSE:3902) 30% Share Price Surge Not Quite Adding Up
Jul 24Medical Data Vision Co., Ltd. (TSE:3902) Soars 28% But It's A Story Of Risk Vs Reward
May 07Calculating The Intrinsic Value Of Medical Data Vision Co., Ltd. (TSE:3902)
Apr 15Medical Data Vision Co., Ltd. (TSE:3902) Stocks Pounded By 30% But Not Lagging Industry On Growth Or Pricing
Mar 08Is Now The Time To Look At Buying Medical Data Vision Co., Ltd. (TSE:3902)?
Feb 11Revenues Not Telling The Story For Medical Data Vision Co., Ltd. (TSE:3902) After Shares Rise 29%
Jan 22Some Investors May Be Worried About Medical Data Vision's (TSE:3902) Returns On Capital
Jan 10Medical Data Vision (TSE:3902) Is Due To Pay A Dividend Of ¥6.50
Dec 20Medical Data Vision (TSE:3902) Will Pay A Dividend Of ¥6.50
Nov 15Medical Data Vision (TSE:3902) Will Pay A Dividend Of ¥6.50
Oct 03Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50
Sep 19Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50
Aug 10Medical Data Vision Co., Ltd. (TSE:3902) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable
Jun 25Why Medical Data Vision Co., Ltd. (TSE:3902) Could Be Worth Watching
Jun 13CEO
Hiroyuki Iwasaki (65 yo)
Mr. Hiroyuki Iwasaki has been the President and Representative Director of Medical Data Vision Co., Ltd. since September 2014 and serves as its Representative Chairman. He joined Shin Nihonkokan Co., Ltd....
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Representative Chairman & President | 11.5yrs | no data | no data | |
| Senior MD | 22.6yrs | no data | 0% ¥ 0 | |
| GM of Business Planning Division | 17.7yrs | no data | 0% ¥ 0 | |
| Head of Sales Division & Director | 8yrs | no data | 0% ¥ 0 | |
| Independent Outside Director | 10yrs | no data | 0% ¥ 0 | |
| Independent Outside Corporate Auditor | 12yrs | no data | no data | |
| Corporate Auditor | 13yrs | no data | no data | |
| Independent Outside Director | 7yrs | no data | 0% ¥ 0 | |
| Independent Outside Corporate Auditor | 8yrs | no data | no data | |
| Independent Outside Full-Time Corporate Auditor | 4yrs | no data | no data | |
| Independent Outside Director | 1yr | no data | no data |
Experienced Board: 3902's board of directors are seasoned and experienced ( 10 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/09 19:01 |
| End of Day Share Price | 2026/03/09 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medical Data Vision Co., Ltd. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yushi Kawamoto | Haitong International Research Limited |
| Masatoshi Nagata | Ichiyoshi Research Institute Inc. |
| Hangil Moon | Jefferies LLC |